Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl

Heather D. Watts, Catherine Spino, Larry Zaborski, David Katzenstein, Scott M. Hammer, Constance A. Benson. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 455-62.

Year

1999

Journal

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication

Abhay H. Patki, Scott F. Purvis, Hernan Valdez, John Spritzler, Elizabeth Connick, Daniel R. Kuritzkes, Harold Kessler, Lawrence Fox, Marty St. Clair, Alan Landay, Michael M. Lederman. HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication. AIDS. 1999. 13: 1177-85.

Year

1999

Journal

AIDS

Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol

Huldrych F. Gunthard, Andrew J. Leigh-Brown, Richard T. D'Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Joseph K. Wong. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology. 1999. 259: 154-65.

Year

1999

Journal

Virology

Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection

Stanley C. Deresinski. Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection. AIDS. 1999. 13: 633-43.

Year

1999

Journal

AIDS

Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection

Mark W. Kline, Suzette Blanchard, Courtney V. Fletcher, Jerry L. Shenep, Ross E. McKinney, Richard Brundage, Mary Culnane, Russell B. Van Dyke, Wayne M. Dankner, Andrea Kovacs, Jim McDowell, Seth Hetherington. Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection. Pediatrics. 1999. 103: 1-5.

Year

1999

Journal

Pediatrics

Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

E. Richard Stiehm, John S. Lambert, Lynne M. Mofenson, James Bethel, Jean Whitehouse, Robert Nugent, John Moye, Mary Glen Fowler, Bonnie Mathieson, Patricia Reichelderfer, Georg J. Nemo, James Korelitz, William A. Meyer, Christine V. Sapan, Eleanor Jimenez, Jorge Gandia, Gwendolyn Scott, Mary Jo O'Sullivan, Andrea Kovacs, Alice Stek, William T. Shearer, Hunter Hammill. Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185. Journal of Infectious Diseases. 1999. 179: 567-75.

Year

1999

Journal

Journal of Infectious Diseases

Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children

Mirochnick M, Ellen Rae Cooper, McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson LM, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura V, Rathore M, Coleen K. Cunningham, James McNamara. Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999. 43: 2586-91.

Year

1999

Journal

Antimicrobial Agents and Chemotherapy

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Cunningham B, Oleske J, Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.. The Journal of the American Medical Association. 1999. 281: 151-157. PMID: 9917118

Year

1999

Journal

The Journal of the American Medical Association

Recent Developments In Pediatric HIV-1 Infection

Burns DN, Mofenson LM. Recent Developments In Pediatric HIV-1 Infection. Lancet. 1999. 354: SII1-6.

Year

1999

Journal

Lancet

Virologic and Immunologic Response To Nucleoside Reverse-Transcriptase Inhibitor therapy Among HIV-Infected Infants and Children

Palumbo P, Raskino C, Fiscus S, Pahwa S, Schutzbank T, Spector S, Baker CJ, Englund JA. Virologic and Immunologic Response To Nucleoside Reverse-Transcriptase Inhibitor therapy Among HIV-Infected Infants and Children. Journal of Infectious Diseases. 1999. 179: 576-83.

Year

1999

Journal

Journal of Infectious Diseases